Extremely low intensity magnetic field effectively improves cognitive impairment in intracerebroventricular streptozotocin animal model sparing septo‐hippocampal cholinergic pathway and CAMKII

Journal article

Avishek Roy, T. Nag, Y. Gupta, S. Jain
Alzheimer's & Dementia, 2021

Cite

APA Click to copy
Roy, A., Nag, T., Gupta, Y., & Jain, S. (2021). Extremely low intensity magnetic field effectively improves cognitive impairment in intracerebroventricular streptozotocin animal model sparing septo‐hippocampal cholinergic pathway and CAMKII. Alzheimer's &Amp; Dementia.

Chicago/Turabian Click to copy
Roy, Avishek, T. Nag, Y. Gupta, and S. Jain. “Extremely Low Intensity Magnetic Field Effectively Improves Cognitive Impairment in Intracerebroventricular Streptozotocin Animal Model Sparing Septo‐Hippocampal Cholinergic Pathway and CAMKII.” Alzheimer's & Dementia (2021).

MLA Click to copy
Roy, Avishek, et al. “Extremely Low Intensity Magnetic Field Effectively Improves Cognitive Impairment in Intracerebroventricular Streptozotocin Animal Model Sparing Septo‐Hippocampal Cholinergic Pathway and CAMKII.” Alzheimer's &Amp; Dementia, 2021.

BibTeX Click to copy

@article{avishek2021a,
  title = {Extremely low intensity magnetic field effectively improves cognitive impairment in intracerebroventricular streptozotocin animal model sparing septo‐hippocampal cholinergic pathway and CAMKII},
  year = {2021},
  journal = {Alzheimer's & Dementia},
  author = {Roy, Avishek and Nag, T. and Gupta, Y. and Jain, S.}
}

Abstract

We have investigated the role of extremely‐low‐frequency magnetic field (ELF‐MF, 17.96µT, 50Hz, 2hr/day for 60 days) exposure on i.c.v. streptozotocin (STZ, 3mg/kg bw, bilaterally, single bolus) induced rat model of AD in a customized chamber.